Clinical Trials Browser

INDUSTRY × Neoplasms × lirilumab × Clear all

NCT01750580 2015-07-22

Safety Study of BMS-986015 (Anti-KIR) in Combination With Ipilimumab in Subjects With Selected Advanced Tumor

Phase 1 Completed

Neoplasms